lacosamide

Generic: lacosamide

Labeler: florida pharmaceutical products, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lacosamide
Generic Name lacosamide
Labeler florida pharmaceutical products, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

lacosamide 50 mg/1

Manufacturer
Florida Pharmaceutical Products, LLC

Identifiers & Regulatory

Product NDC 71921-220
Product ID 71921-220_85fd1828-d3d9-4b4b-965b-7ed7ef5f5e97
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA208308
DEA Schedule cv
Listing Expiration 2026-12-31
Marketing Start 2023-09-21

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71921220
Hyphenated Format 71921-220

Supplemental Identifiers

RxCUI
809987 809992 809996 810000
UPC
0371921221066 0371921222063 0371921223060
UNII
563KS2PQY5
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lacosamide (source: ndc)
Generic Name lacosamide (source: ndc)
Application Number ANDA208308 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (71921-220-06)
source: ndc

Packages (1)

71921-220-06 60 TABLET in 1 BOTTLE (71921-220-06)

Ingredients (1)

lacosamide (50 mg/1)

Linked Drug Pages (1)

Lacosamide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "85fd1828-d3d9-4b4b-965b-7ed7ef5f5e97", "openfda": {"nui": ["N0000008486"], "upc": ["0371921221066", "0371921222063", "0371921223060"], "unii": ["563KS2PQY5"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_set_id": ["3680c0ff-7f5c-4572-b1eb-4fea96b7fbe2"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Florida Pharmaceutical Products, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71921-220-06)", "package_ndc": "71921-220-06", "marketing_start_date": "20230921"}], "brand_name": "Lacosamide", "product_id": "71921-220_85fd1828-d3d9-4b4b-965b-7ed7ef5f5e97", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71921-220", "dea_schedule": "CV", "generic_name": "Lacosamide", "labeler_name": "Florida Pharmaceutical Products, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lacosamide", "active_ingredients": [{"name": "LACOSAMIDE", "strength": "50 mg/1"}], "application_number": "ANDA208308", "marketing_category": "ANDA", "marketing_start_date": "20230921", "listing_expiration_date": "20261231"}